Sarepta Therapeutics Inc (0L35)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.42M | 154.58M | 301.03M | 380.83M | 540.1M | 701.89M | 933.01M | 1.24B |
| Operating Income | -266.73M | -171.64M | -343.63M | -705.56M | -564.16M | -459.71M | -536.2M | -267.82M |
| Pre Tax Income | -267.27M | -48.63M | -362.61M | -713.88M | -553.07M | -418.95M | -689.96M | -520.1M |
| Net Income | -267.27M | -50.69M | -361.92M | -715.08M | -554.13M | -418.78M | -703.49M | -535.98M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -4.881 | -0.782 | -5.092 | -9.511 | -6.981 | -4.807 | -7.999 | -5.729 |
| EBIT | -266.73M | -44.66M | -335.71M | -690.45M | -496.09M | -358.49M | -525.19M | -116.7M |
| EBITDA | -261.12M | -163.55M | -328.06M | -681.51M | -537.7M | -421.8M | -494.39M | -221.87M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
